Literature DB >> 16382249

Inflammatory tumour of the retroperitoneum--a case report.

V P Mali1, H C Tan, D Loh, K Prabhakaran.   

Abstract

INTRODUCTION: Neoplastic growths of myofibroblasts occurring on a background of plasma cell and lymphocytic proliferation have been designated as inflammatory myofibroblastic tumours (IMTs). These unusual tumours were first described in pulmonary location in adults. Though extrapulmonary masses have been reported in children; retroperitoneal growths are exceedingly rare. We report a case of retroperitoneal IMT that presented with constitutional symptoms without any palpable abdominal mass. CLINICAL PICTURE: A previously well 12-year-old boy presented with fever, right-sided flank pain and weight loss of 1-month duration. There were no foci of infection. The erythrocyte sedimentation rate (ESR) was raised; the white cell count was normal. An abdominal computed tomography (CT) scan revealed a right suprarenal tumour measuring 3.5 cm without any calcification. The urinary catecholamines and vanilmandelic acid were normal. TREATMENT: A laparotomy with complete excision of the tumour was performed. Final histology revealed an inflammatory myofibroblastic tumour without any correlates of aggressive behaviour. OUTCOME: Postoperatively, the constitutional symptoms of fever, weight loss and raised ESR normalised. Follow-up CT was normal and further treatment was not necessary.
CONCLUSION: Although rare, IMTs should be considered in any abdominal solid tumour with associated constitutional and laboratory features of an inflammatory response. Complete surgical excision is effective treatment for biologically benign tumours.

Entities:  

Mesh:

Year:  2005        PMID: 16382249

Source DB:  PubMed          Journal:  Ann Acad Med Singap        ISSN: 0304-4602            Impact factor:   2.473


  9 in total

1.  Recurrent retroperitoneal inflammatory myofibroblastic tumor: A case report.

Authors:  Xinjun Wang; Xiaokun Zhao; Joseph Chin; Liang Zhu; Zijian Wang; Zhaohui Zhong
Journal:  Oncol Lett       Date:  2016-06-23       Impact factor: 2.967

2.  Computed tomography appearance of inflammatory myofibroblastic tumor in the abdomen: CT features and pathologic correlation.

Authors:  Bo Liu; Junlong Xu; Jiaxin Wang; Hongguang Fan; Xuan Ang; Wenming Liu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Huge pelvi-abdominal malignant inflammatory myofibroblastic tumor with rapid recurrence in a 14-year-old boy.

Authors:  Chia-Hsun Lu; Hsuan-Ying Huang; Han-Koo Chen; Jiin-Haur Chuang; Shu-Hang Ng; Sheung-Fat Ko
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

4.  Inflammatory Myofibroblastic Tumour.

Authors:  Pedro Pimentel Duarte; Rafaela Sousa; Mariana Chaves; Natacha Amaral; César Lourenço
Journal:  Eur J Case Rep Intern Med       Date:  2020-06-16

5.  Different imaging findings of inflammatory myofibroblastic tumor of the liver.

Authors:  Xiao-Fei Liu; Bao-Ming He; Xiao-Hui Ou-Yang; Zhi-Zhong Wang; Jia-Gui Su
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

6.  Inflammatory myofibroblastic tumor of mesentery: a case report.

Authors:  Imtiaz Wani
Journal:  J Gastrointest Cancer       Date:  2007

7.  Mesenteric inflammatory myofibroblastic tumors in an elder patient with early recurrence: a case report.

Authors:  Sheng-Shih Chen; Shiuh-Inn Liu; King-Tong Mok; Being-Whey Wang; Ming-Hsin Yeh; Yu-Chia Chen; I-Shu Chen
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

8.  A rare case of an inflammatory myofibroblastic tumor in a middle-aged female.

Authors:  Lamprini Kosma; Lubna Khaldi; Panagiota Galani; Dimitrios Mytas; Sofia Lafoyianni
Journal:  Case Rep Oncol Med       Date:  2012-10-04

9.  Retroperitoneal Inflammatory Myofibroblastic Tumor: Case Report and Immunohistochemistry Study.

Authors:  Sonia Ziadi; Mounir Trimeche; Sarra Mestiri; Wafa Joma; Moncef Mokni; Rached Lataif; Badreddine Sriha; Sadok Korbi
Journal:  World J Oncol       Date:  2010-04-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.